Synthesis Of Triazolopyrimidine Compounds

Patent No. EP2755957 (titled "Synthesis Of Triazolopyrimidine Compounds") was filed by LEK Pharmaceuticals DD on Sep 14, 2012. The application was issued on May 15, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBB	Aug 1, 2017	GRUNECKER PATENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Apr 18, 2019
Decision to maintain the European patent in amended form
Apr 18, 2019
Decision to maintain the European patent in amended form
Apr 12, 2019
Termination of the opposition proceedings with maintenance of patent
Apr 9, 2019
(Electronic) Receipt
Apr 9, 2019
Clean copy of description pages in the opposition procedure
Apr 9, 2019
Druckexemplar in opposition procedure
Apr 9, 2019
Filing of the translation of the amended claims
Apr 9, 2019
Letter accompanying subsequently filed items
Apr 2, 2019
(Electronic) Receipt
Apr 2, 2019
Filing of the translation of the amended claims
Apr 2, 2019
French translation of claims
Apr 2, 2019
German translation of the claims
Feb 15, 2019
Communication of bibliographic data
Feb 15, 2019
Communication to opponent concerning maintenance
Feb 15, 2019
Communication with request to file translations
Feb 11, 2019
Maintenance of the patent with the documents specified in the final decision
Jan 17, 2019
Refund of fees
Jan 16, 2019
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Jan 16, 2019
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Jan 8, 2019
Composition of the board (T)
Jan 2, 2019
Withdrawal of an appeal
Dec 17, 2018
F3204 Communication of the file number to the parties
Dec 17, 2018
F3204 Communication of the file number to the parties
Dec 7, 2018
(Electronic) Receipt
Dec 7, 2018
Letter accompanying subsequently filed items
Dec 7, 2018
Notice of appeal
Dec 7, 2018
Processing of an appeal
Oct 22, 2018
Advice of delivery
Oct 18, 2018
Advice of delivery
Oct 18, 2018
Advice of delivery
Oct 16, 2018
Advice of delivery
Oct 15, 2018
Acknowledgement of a document
Oct 15, 2018
Acknowledgement of a document
Oct 15, 2018
Annex to the communication - opposition
Oct 15, 2018
Decision of the Opposition Division and instruction
Oct 15, 2018
Grounds for the decision (Annex) - opposition
Oct 15, 2018
Interlocutory decision in opposition proceedings
Oct 15, 2018
Internal form - Opposition/addressees
Oct 15, 2018
Internal form - Opposition/addressees
Oct 15, 2018
Means of redress
Oct 15, 2018
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Oct 15, 2018
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
Oct 15, 2018
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
Oct 15, 2018
OPPODREX with handwritten amendments
Oct 15, 2018
Provision of a copy of the minutes - opposition procedure
Oct 8, 2018
Application deemed to be withdrawn ( translations of claims/payment missing)
Sep 21, 2018
Brief communication - Opposition proceedings
Sep 18, 2018
Result of consultation by telephone/in person
Sep 17, 2018
Information about the result of oral proceedings
Sep 13, 2018
Non-patent literature cited during the opposition procedure
Sep 13, 2018
Written submission in preparation to/during oral proceedings
Jul 23, 2018
Brief communication - Opposition proceedings
Jul 17, 2018
Brief communication - Opposition proceedings
Jul 16, 2018
Request for interpreters during oral proceedings
Jul 10, 2018
Amended claims with annotations
Jul 10, 2018
Amended claims with annotations
Jul 10, 2018
Amended claims with annotations
Jul 10, 2018
Claims
Jul 10, 2018
Claims
Jul 10, 2018
Claims
Jul 10, 2018
Written submission in preparation to/during oral proceedings
Mar 12, 2018
Advice of delivery
Mar 8, 2018
Advice of delivery
Mar 8, 2018
Advice of delivery
Mar 7, 2018
Advice of delivery
Mar 5, 2018
Acknowledgement of a document
Mar 5, 2018
Acknowledgement of a document
Mar 5, 2018
Annex to the communication - opposition
Mar 5, 2018
Information concerning oral proceedings
Mar 5, 2018
Summons to attend oral proceedings
Mar 5, 2018
Summons to attend oral proceedings
Feb 28, 2018
Preparation for oral proceedings
Jan 22, 2018
Brief communication - Opposition proceedings
Jan 4, 2018
Main request during Opposition procedure
Jan 4, 2018
Main request during Opposition procedure
Jan 4, 2018
Reply of the patent proprietor to the notice(s) of opposition
Sep 6, 2017
Communication of a notice of opposition and request to file observations
Sep 6, 2017
Notice of further oppositions to opponent(s)
Aug 8, 2017
Communication of a notice of opposition - first information to patent proprietor
Aug 1, 2017
(Electronic) Receipt
Aug 1, 2017
Citation in opposition procedure
Aug 1, 2017
Notice of opposition
Aug 1, 2017
Notice of opposition
Aug 1, 2017
Patent document cited during the opposition procedure
Aug 1, 2017
Patent document cited during the opposition procedure
Aug 1, 2017
Patent document cited during the opposition procedure
Aug 1, 2017
Patent document cited during the opposition procedure
Aug 1, 2017
Patent document cited during the opposition procedure
Nov 3, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Oct 7, 2016
Decision to grant a European patent
Sep 21, 2016
(Electronic) Receipt
Sep 21, 2016
French translation of claims
Sep 21, 2016
German translation of the claims
Sep 21, 2016
Letter accompanying subsequently filed items
May 23, 2016
Bibliographic data of the European patent application
May 23, 2016
Communication about intention to grant a European patent
May 23, 2016
Intention to grant (signatures)
May 23, 2016
Text intended for grant (clean copy)
May 23, 2016
Text intended for grant (version for approval)
Feb 16, 2016
Amended claims with annotations
Feb 16, 2016
Claims
Feb 16, 2016
Reply to communication from the Examining Division
Dec 11, 2015
Submission concerning representation
Oct 9, 2015
Annex to the communication
Oct 9, 2015
Communication from the Examining Division
Oct 28, 2014
Amendments received before examination
Jun 25, 2014
Notification on forthcoming publication of bibliographic data
May 20, 2014
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
May 13, 2014
Priority search results copy provided by EPO
Apr 22, 2014
Communication to designated inventor
Apr 22, 2014
Communication to designated inventor
Apr 8, 2014
(Electronic) Receipt
Apr 8, 2014
Request for entry into the European phase
Apr 1, 2014
Copy of the international preliminary report on patentability
Jan 24, 2014
Information on entry into European phase
Apr 9, 2013
Priority document (electronically transmitted)
Apr 9, 2013
Priority document (electronically transmitted)
Apr 9, 2013
Priority document (electronically transmitted)
Mar 21, 2013
Copy of the international search report
Mar 21, 2013
Published international application - A1
Nov 6, 2012
Written opinion of the ISA, boxes No. I to VIII
Nov 6, 2012
Written opinion of the ISA, cover sheet
Nov 6, 2012
Written opinion of the ISA, supplemental box
Sep 14, 2012
(Electronic) Receipt
Sep 14, 2012
Abstract
Sep 14, 2012
Claims
Sep 14, 2012
Description
Sep 14, 2012
Priority document (RO-procedure)
Sep 14, 2012
Priority document (RO-procedure)
Sep 14, 2012
Priority document (RO-procedure)

EP2755957

LEK PHARMACEUTICALS DD

Application Number: EP12759136A
Filing Date: Sep 14, 2012
Status: Patent Maintained As Amended; Apr 12, 2019
Publication Date: May 15, 2019
External Links: Slate, Register , Google Patents

IP Verse

Synthesis Of Triazolopyrimidine Compounds

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2755957